VVUS 4.0
VIVUS, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products to restore sexual function in women and men. Its products in pipeline include four clinical stage product candidates, including Evamist, a Phase III clinical trial product, which would be used to alleviate symptoms associated with menopause; Avanafil, a Phase II clinical trial completed product, for the treatment of erectile dysfunction; ALISTA, a Phase IIB clinical trial product, for the treatment of female sexual arousal disorder; and Testosterone MDTS, a Phase II clinical trial completed product, for the treatment of hypoactive sexual desire disorder. The company also offers MUSE for the treatment of erectile dysfunction.
 |
